Pulmonary Arterial Hypertension Treatment Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Vasodilators
1.2.3 Phosphodiesterase 5 (PDE 5) Inhibitors
1.2.4 Endothelin Receptor Antagonists (ERA)
1.2.5 Soluble Guanylate Cyclase (SGC) Stimulator
1.3 Market by Application
1.3.1 Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Arterial Hypertension Treatment Market Perspective (2017-2028)
2.2 Pulmonary Arterial Hypertension Treatment Growth Trends by Region
2.2.1 Pulmonary Arterial Hypertension Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pulmonary Arterial Hypertension Treatment Historic Market Size by Region (2017-2022)
2.2.3 Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Region (2023-2028)
2.3 Pulmonary Arterial Hypertension Treatment Market Dynamics
2.3.1 Pulmonary Arterial Hypertension Treatment Industry Trends
2.3.2 Pulmonary Arterial Hypertension Treatment Market Drivers
2.3.3 Pulmonary Arterial Hypertension Treatment Market Challenges
2.3.4 Pulmonary Arterial Hypertension Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Arterial Hypertension Treatment Players by Revenue
3.1.1 Global Top Pulmonary Arterial Hypertension Treatment Players by Revenue (2017-2022)
3.1.2 Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Pulmonary Arterial Hypertension Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pulmonary Arterial Hypertension Treatment Revenue
3.4 Global Pulmonary Arterial Hypertension Treatment Market Concentration Ratio
3.4.1 Global Pulmonary Arterial Hypertension Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Arterial Hypertension Treatment Revenue in 2021
3.5 Pulmonary Arterial Hypertension Treatment Key Players Head office and Area Served
3.6 Key Players Pulmonary Arterial Hypertension Treatment Product Solution and Service
3.7 Date of Enter into Pulmonary Arterial Hypertension Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Arterial Hypertension Treatment Breakdown Data by Type
4.1 Global Pulmonary Arterial Hypertension Treatment Historic Market Size by Type (2017-2022)
4.2 Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Type (2023-2028)
5 Pulmonary Arterial Hypertension Treatment Breakdown Data by Application
5.1 Global Pulmonary Arterial Hypertension Treatment Historic Market Size by Application (2017-2022)
5.2 Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pulmonary Arterial Hypertension Treatment Market Size (2017-2028)
6.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Type
6.2.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022)
6.2.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028)
6.2.3 North America Pulmonary Arterial Hypertension Treatment Market Share by Type (2017-2028)
6.3 North America Pulmonary Arterial Hypertension Treatment Market Size by Application
6.3.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022)
6.3.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028)
6.3.3 North America Pulmonary Arterial Hypertension Treatment Market Share by Application (2017-2028)
6.4 North America Pulmonary Arterial Hypertension Treatment Market Size by Country
6.4.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2017-2022)
6.4.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pulmonary Arterial Hypertension Treatment Market Size (2017-2028)
7.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type
7.2.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022)
7.2.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028)
7.2.3 Europe Pulmonary Arterial Hypertension Treatment Market Share by Type (2017-2028)
7.3 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application
7.3.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022)
7.3.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028)
7.3.3 Europe Pulmonary Arterial Hypertension Treatment Market Share by Application (2017-2028)
7.4 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country
7.4.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2017-2022)
7.4.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size (2017-2028)
8.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type
8.2.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application
8.3.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region
8.4.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size (2017-2028)
9.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type
9.2.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Pulmonary Arterial Hypertension Treatment Market Share by Type (2017-2028)
9.3 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application
9.3.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Pulmonary Arterial Hypertension Treatment Market Share by Application (2017-2028)
9.4 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country
9.4.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size (2017-2028)
10.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type
10.2.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application
10.3.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country
10.4.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Pulmonary Arterial Hypertension Treatment Introduction
11.1.4 GSK Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
11.1.5 GSK Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Introduction
11.2.4 Eli Lilly and Company Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
11.2.5 Eli Lilly and Company Recent Developments
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Details
11.3.2 Pfizer Inc Business Overview
11.3.3 Pfizer Inc Pulmonary Arterial Hypertension Treatment Introduction
11.3.4 Pfizer Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
11.3.5 Pfizer Inc Recent Developments
11.4 Actelion Inc
11.4.1 Actelion Inc Company Details
11.4.2 Actelion Inc Business Overview
11.4.3 Actelion Inc Pulmonary Arterial Hypertension Treatment Introduction
11.4.4 Actelion Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
11.4.5 Actelion Inc Recent Developments
11.5 United Therapeutic Corporation
11.5.1 United Therapeutic Corporation Company Details
11.5.2 United Therapeutic Corporation Business Overview
11.5.3 United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Introduction
11.5.4 United Therapeutic Corporation Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
11.5.5 United Therapeutic Corporation Recent Developments
11.6 SteadyMed Ltd
11.6.1 SteadyMed Ltd Company Details
11.6.2 SteadyMed Ltd Business Overview
11.6.3 SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Introduction
11.6.4 SteadyMed Ltd Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
11.6.5 SteadyMed Ltd Recent Developments
11.7 Gilead Sciences, Inc
11.7.1 Gilead Sciences, Inc Company Details
11.7.2 Gilead Sciences, Inc Business Overview
11.7.3 Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Introduction
11.7.4 Gilead Sciences, Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
11.7.5 Gilead Sciences, Inc Recent Developments
11.8 Teva Pharmaceuticals Inc
11.8.1 Teva Pharmaceuticals Inc Company Details
11.8.2 Teva Pharmaceuticals Inc Business Overview
11.8.3 Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Introduction
11.8.4 Teva Pharmaceuticals Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
11.8.5 Teva Pharmaceuticals Inc Recent Developments
11.9 Bayer AG
11.9.1 Bayer AG Company Details
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG Pulmonary Arterial Hypertension Treatment Introduction
11.9.4 Bayer AG Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
11.9.5 Bayer AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Vasodilators
Table 3. Key Players of Phosphodiesterase 5 (PDE 5) Inhibitors
Table 4. Key Players of Endothelin Receptor Antagonists (ERA)
Table 5. Key Players of Soluble Guanylate Cyclase (SGC) Stimulator
Table 6. Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Pulmonary Arterial Hypertension Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Pulmonary Arterial Hypertension Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Pulmonary Arterial Hypertension Treatment Market Share by Region (2017-2022)
Table 10. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Pulmonary Arterial Hypertension Treatment Market Share by Region (2023-2028)
Table 12. Pulmonary Arterial Hypertension Treatment Market Trends
Table 13. Pulmonary Arterial Hypertension Treatment Market Drivers
Table 14. Pulmonary Arterial Hypertension Treatment Market Challenges
Table 15. Pulmonary Arterial Hypertension Treatment Market Restraints
Table 16. Global Pulmonary Arterial Hypertension Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Pulmonary Arterial Hypertension Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Pulmonary Arterial Hypertension Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Arterial Hypertension Treatment as of 2021)
Table 19. Ranking of Global Top Pulmonary Arterial Hypertension Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Pulmonary Arterial Hypertension Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pulmonary Arterial Hypertension Treatment Product Solution and Service
Table 23. Date of Enter into Pulmonary Arterial Hypertension Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Pulmonary Arterial Hypertension Treatment Revenue Share by Application (2017-2022)
Table 31. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Pulmonary Arterial Hypertension Treatment Revenue Share by Application (2023-2028)
Table 33. North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. GSK Company Details
Table 64. GSK Business Overview
Table 65. GSK Pulmonary Arterial Hypertension Treatment Product
Table 66. GSK Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022) & (US$ Million)
Table 67. GSK Recent Developments
Table 68. Eli Lilly and Company Company Details
Table 69. Eli Lilly and Company Business Overview
Table 70. Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Product
Table 71. Eli Lilly and Company Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022) & (US$ Million)
Table 72. Eli Lilly and Company Recent Developments
Table 73. Pfizer Inc Company Details
Table 74. Pfizer Inc Business Overview
Table 75. Pfizer Inc Pulmonary Arterial Hypertension Treatment Product
Table 76. Pfizer Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022) & (US$ Million)
Table 77. Pfizer Inc Recent Developments
Table 78. Actelion Inc Company Details
Table 79. Actelion Inc Business Overview
Table 80. Actelion Inc Pulmonary Arterial Hypertension Treatment Product
Table 81. Actelion Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022) & (US$ Million)
Table 82. Actelion Inc Recent Developments
Table 83. United Therapeutic Corporation Company Details
Table 84. United Therapeutic Corporation Business Overview
Table 85. United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Product
Table 86. United Therapeutic Corporation Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022) & (US$ Million)
Table 87. United Therapeutic Corporation Recent Developments
Table 88. SteadyMed Ltd Company Details
Table 89. SteadyMed Ltd Business Overview
Table 90. SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Product
Table 91. SteadyMed Ltd Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022) & (US$ Million)
Table 92. SteadyMed Ltd Recent Developments
Table 93. Gilead Sciences, Inc Company Details
Table 94. Gilead Sciences, Inc Business Overview
Table 95. Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Product
Table 96. Gilead Sciences, Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022) & (US$ Million)
Table 97. Gilead Sciences, Inc Recent Developments
Table 98. Teva Pharmaceuticals Inc Company Details
Table 99. Teva Pharmaceuticals Inc Business Overview
Table 100. Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Product
Table 101. Teva Pharmaceuticals Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022) & (US$ Million)
Table 102. Teva Pharmaceuticals Inc Recent Developments
Table 103. Bayer AG Company Details
Table 104. Bayer AG Business Overview
Table 105. Bayer AG Pulmonary Arterial Hypertension Treatment Product
Table 106. Bayer AG Revenue in Pulmonary Arterial Hypertension Treatment Business (2017-2022) & (US$ Million)
Table 107. Bayer AG Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary Arterial Hypertension Treatment Market Share by Type: 2021 VS 2028
Figure 2. Vasodilators Features
Figure 3. Phosphodiesterase 5 (PDE 5) Inhibitors Features
Figure 4. Endothelin Receptor Antagonists (ERA) Features
Figure 5. Soluble Guanylate Cyclase (SGC) Stimulator Features
Figure 6. Global Pulmonary Arterial Hypertension Treatment Market Share by Application: 2021 VS 2028
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Pulmonary Arterial Hypertension Treatment Report Years Considered
Figure 11. Global Pulmonary Arterial Hypertension Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Pulmonary Arterial Hypertension Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pulmonary Arterial Hypertension Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Pulmonary Arterial Hypertension Treatment Market Share by Players in 2021
Figure 15. Global Top Pulmonary Arterial Hypertension Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Arterial Hypertension Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Pulmonary Arterial Hypertension Treatment Revenue in 2021
Figure 17. North America Pulmonary Arterial Hypertension Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Pulmonary Arterial Hypertension Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America Pulmonary Arterial Hypertension Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America Pulmonary Arterial Hypertension Treatment Market Size Share by Country (2017-2028)
Figure 21. United States Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Pulmonary Arterial Hypertension Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Pulmonary Arterial Hypertension Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe Pulmonary Arterial Hypertension Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe Pulmonary Arterial Hypertension Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Pulmonary Arterial Hypertension Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Pulmonary Arterial Hypertension Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Pulmonary Arterial Hypertension Treatment Market Size Share by Region (2017-2028)
Figure 37. China Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Pulmonary Arterial Hypertension Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Pulmonary Arterial Hypertension Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Pulmonary Arterial Hypertension Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Pulmonary Arterial Hypertension Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Pulmonary Arterial Hypertension Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Pulmonary Arterial Hypertension Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Pulmonary Arterial Hypertension Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. GSK Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
Figure 58. Pfizer Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
Figure 59. Actelion Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
Figure 60. United Therapeutic Corporation Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
Figure 61. SteadyMed Ltd Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
Figure 62. Gilead Sciences, Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
Figure 63. Teva Pharmaceuticals Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
Figure 64. Bayer AG Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Industry Market Size
